Covaxin found to neutralise 617 variant of COVID-19, says Dr. Fauci

Developed by Bharat Biotech in partnership with National Institute of Virology and the Indian Council of Medical Research, trial results have showed that Covaxin has an efficacy of 78%.

Read more here:: Post India Listing